Senior Director of Regulatory Affairs, Biofourmis

Salary not provided
Expert level
Boston
Remote from US
Biofourmis

ML-driven predictive analytics platform for healthcare

Job no longer available

Biofourmis

ML-driven predictive analytics platform for healthcare

101-200 employees

HealthcareB2BArtificial IntelligenceAnalyticsMachine LearningSaaSData Analysis

Job no longer available

Salary not provided
Expert level
Boston
Remote from US

101-200 employees

HealthcareB2BArtificial IntelligenceAnalyticsMachine LearningSaaSData Analysis

Company mission

To harness the power of technology and data to shape innovations that bring the right care to every person, no matter where they are.

Company mission

To harness the power of technology and data to shape innovations that bring the right care to every person, no matter where they are.

Top investors

4% employee growth in 12 months

Our take

Data provides the means for analysts to predict all manner of life events, including using health data to predict patient deterioration. However, aggregating and analysing data is such a time-consuming process that it is almost impossible to get a holistic view of a patient's health and predict the best courses of action.

Biofourmis provides a predictive analytics platform for healthcare, aggregating patient data and using ML to analyse it. This streamlines connections between patients and care teams, and helps better predict health outcomes. The platform integrates with existing software, helping to reduce healthcare costs by increasing data transparency, optimising care plans, and reducing re-admission rates.

Whilst the company faces competition from other ML-driven healthcare data analysis platforms, Biofourmis stands out by providing its services to all parties, not just healthcare providers - an approach which provides the benefits of AI-assisted healthcare whilst reducing existing communication friction. Having surpassed Unicorn status in 2022, the company has been focused on expanding operations, including by scaling its virtual care offerings and securing high-value partnerships.

Kirsty headshot

Kirsty

Company Specialist at Welcome to the Jungle

Funding (last 2 of 9 rounds)

Aug 2022

$20m

SERIES D

Apr 2022

$300m

SERIES D

Total funding: $463.6m

This company has top investors

Leadership

Maulik Majmudar, M.D.

(Chief Medical Officer & Co-founder)

Research Fellow in Cardiovascular Medicine and Associate Director of the Healthcare Transformation Lab for Massachusetts General Hospital from 2011 to 2018. Medical Advisor for Amazon from 2018 to 2021, and for HILABSINC since 2016.

David Koretz

(CEO & Co-founder)

Previously Board Member at Plum Inc, was on the Board of Directors for BlueBox Security and EarthLink and was Corporate VP of Juniper Networks.

Steve McKenzie

(CRO & Co-founder)

Was the VP of CoPilotIQ, a National Director at Paychex and was a VP at Dollar Financial Group.

Job (1)

Software Engineering